Akumentis Healthcare posts Rs 66 Cr profit in FY25, revenue grows 9%

Akumentis Healthcare, a pharmaceutical company, reported a profit of Rs 66 crore in the fiscal year ending March 2025, marking a 16.8% increase compared to FY24. The company achieved this growth on the back of consistent revenue and controlled operating costs.

Akumentis’ revenue from operations grew by 9% to Rs 433.5 crore in FY25 from Rs 398 crore in FY24, according to its financial statement sourced from the Registrar of Companies (RoC).

Akumentis Healthcare operates on a branded formulations model, focusing on prescription-driven pharmaceuticals…